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Background: Iliac artery endoconduits (ECs) have emerged as important alternatives to retroperitoneal open iliac conduits
(ROICs) to aid in transfemoral delivery for thoracic endovascular aortic repair (TEVAR). We present, to our knowledge,
the ﬁrst comparative analysis between these alternative approaches.
Methods: All patients undergoing TEVAR with either ROIC (n[ 23) or internal EC (n[ 16) were identiﬁed. The mean
age of the cohort was 72.4 6 11.5 years (82.1% female). Device delivery was accomplished in 100% of cases. The primary
outcome was the presence of iliofemoral complications, which was deﬁned as: (1) the inability to successfully deliver the
device into the aorta via the ROIC or EC approach; (2) rupture, dissection, or thrombosis of the ipsilateral iliac or femoral
artery; and/or (3) retroperitoneal hematoma requiring exploration and evacuation. Secondary outcomes were 30-day
mortality and rates of limb loss, claudication, or revascularization.
Results: At a median follow-up of 10.1 months, the incidence of iliofemoral complications was less for the EC approach
compared with the ROIC technique (12.5% vs 26.1%; P[ .301). No patients sustained limb loss. Revascularization was
performed in two patients after ROIC. Lower extremity claudication occurred in one patient after EC. Early mortality
was seen in one patient who underwent EC. Two-year Kaplan-Meier survival for the entire cohort was 74.4%, and did not
differ between groups (ROIC, 78.3% vs EC, 68.8%; P [ .350). Two-year Kaplan-Meier freedom from limb loss, clau-
dication, or revascularization did not differ between the two approaches (ROIC, 91.3% vs EC, 93.8%; P [ .961).
Conclusions: Results of this early comparative evaluation of alternative access routes for TEVAR suggest that an EC
approach is safe, effective, and associated with low rates of early mortality and late iliofemoral complications. In selected
patients, the ECmay be considered an appropriate delivery route for transfemoral TEVAR. (J Vasc Surg 2014;60:1168-76.)Endovascular techniques, such as thoracic endovascular
aortic repair (TEVAR) and transcatheter aortic valve
replacement have been successfully introduced as less inva-
sive treatment modalities for thoracic aortic pathology.1-4
Nevertheless, TEVAR is associated with access and device
delivery challenges and alternative access techniques can
be used to deliver the stent graft with TEVAR when a stan-
dard transfemoral access is not feasible. We have previously
suggested that iliofemoral complications in patients who
undergo transfemoral TEVAR are predicted by the differ-
ence between the average iliac diameter and sheath size,
increased iliac artery morphology score, and preoperative
ankle-brachial index (ABI).5 Furthermore, iliofemoral
complications reduced late survival rates primarily because
of high mortality rates within the ﬁrst year.5 To reducethe Departments of Cardiac Surgery,a Radiology,b and Vascular
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8iliofemoral complications, various approaches have been
performed to avoid arterial access limitations during
TEVAR, with most requiring retroperitoneal access or
aggressive angioplasty, potentially leading to life-
threatening complications.6-9
When TEVAR candidates have unfavorable iliac artery
anatomy, including a small-caliber iliac artery, iliac artery
tortuosity, or occlusive disease, in combination with the
need for large-diameter delivery sheaths, the retroperito-
neal open iliac conduit (ROIC) has been considered the
most appropriate route for stent graft delivery.10 This
approach requires either intra-abdominal or retroperitoneal
access vessel exposure, resulting in a more complex surgical
plan and extended postoperative recovery.7 More recently,
the internal endoconduit (EC) approach has been intro-
duced as an alternative for stent graft delivery, and can be
performed using a standard femoral approach.11 To
explore the initial applicability of these techniques in pa-
tients at high risk for iliofemoral complications, we present
an early comparative analysis between ROIC and EC as
alternative stent graft delivery approaches with TEVAR.
METHODS
This single-center retrospective study was approved
by the Institutional Review Board of the University of
Michigan Medical School (HUM00053164; informed
consent waived). All patients undergoing TEVAR from
December 1993 to February 2014 were reviewed for study
Table I. Iliac artery morphology score
Attribute Absent ¼ 0 Mild ¼ 1 Moderate ¼ 2 Severe ¼ 3
Calciﬁcation None <25% vessel length 25%-50% vessel length >50% vessel length
Average diameter (d) d >10 mm d < 8 < 10 mm d < 7 < 8 mm d <7 mm
Iliac tortuosity index (s) s <1.25 s < 1.25 < 1.5 s < 1.5 < 1.6 s >1.6
Adapted from Vandy et al with permission of Elsevier.5
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(n ¼ 16) approaches were included for analysis. Preopera-
tive demographic characteristics and postoperative out-
comes for these patients were retrospectively collected.
The primary outcome of this study was the incidence of
iliofemoral complications, which is deﬁned as: (1) inability
to successfully deliver the device into the aorta via the
ROIC or EC approach; (2) free rupture, dissection, or
thrombosis of the ipsilateral iliac or femoral artery; and/
or (3) retroperitoneal hematoma requiring exploration
and evacuation. Secondary outcomes included 30-day
mortality, and late rates of limb loss, claudication, or
revascularization.
In 2002, the iliac morphology score (IMS) was intro-
duced, which includes the longitudinal extent of calciﬁca-
tion, the vessel diameter or occlusive disease, and the
tortuosity of the iliac artery.12 Modiﬁcation of this IMS
was reported previously by us and is shown in Table I.5
To calculate the IMS, all available three-dimensional recon-
structions of the iliofemoral tract were evaluated. The tor-
tuosity index was determined by the ratio of the iliac artery
length along the centerline of blood ﬂow and the geomet-
ric straight line from the aortoiliac bifurcation to the distal
external iliac artery at the inguinal ligament.5
Procedural details. All TEVAR procedures in this
study were performed in hybrid operating rooms using
general anesthesia. A standard ROIC approach in our insti-
tution is performed through an oblique incision in the
lower abdominal quadrant, deepened to the preperitoneal
and subsequently the retroperitoneal space, with exposure
of the common, external, and internal iliac artery. Subse-
quently, the patient is heparinized and vessel control is
established proximally and distally. The iliac artery is
dissected and a 10-mm Dacron conduit is positioned and
sutured to the iliac artery with a polypropylene suture in an
end-to-side fashion. After completion of the thoracic stent
graft(s) deployment, the conduit is either oversewn at its
base, or anastomosed to the distal external iliac artery just
above the inguinal ligament in a standard fashion.
The EC technique is performed through a standard
transverse infrainguinal incision to expose the common
femoral artery. In three EC patients (18.8%), iliac angio-
plasty or dilatation was performed without success, before
the EC approach was chosen. After an iliac arteriogram,
Viabahn-covered stents (W. L. Gore & Associates, Flag-
staff, Ariz) are placed across the critical stenotic iliac artery
segment, extending proximal and distal to the lesion. The
median number of Viabahn stent grafts used was two(range, 1-4), with a median diameter of 10 mm (range,
10-13 mm) and a median length of 100 mm (range, 50-
150 mm). The most commonly used Viabahn stent graft
(in 40% of patients) was 10 mm in diameter and
100 mm in length. After deployment of the EC, angio-
plasty with a noncompliant balloon and controlled rupture
of the iliac artery was performed. In six EC patients, both
the common and external iliac artery were intentionally
ruptured: in four of these patients the common and
external iliac artery were ruptured over the entire segment,
in one patient the common and external iliac artery junc-
tion, and proximal and midportion of the external iliac ar-
tery were ruptured, and in one patient the proximal
common iliac artery and the midportion of the external iliac
artery were ruptured with preservation of the hypogastric
artery with a widely patent origin. In the remaining 10
EC patients only the external iliac artery was intentionally
ruptured. In eight of these patients, the external iliac artery
was ruptured over the entire segment, in one patient the
distal portion, and in one patient the midportion of the
external iliac artery only. Coverage with the EC of the ipsi-
lateral hypogastric artery was required in six EC patients
(37.5%). Preoperative angiographic evaluation was per-
formed in all patients and none required hypogastric embo-
lization before controlled iliac artery rupture. After
controlled rupture, the stent graft delivery sheath was
advanced through the external and common iliac arteries
through the EC(s) into the aorta. After deployment of
the thoracic stent graft(s), the femoral artery was either pri-
mary repaired with polypropylene suture or with a bovine
pericardial patch angioplasty. The different key steps of
the EC technique are shown in Fig 1. Alternatives of the
EC approach are also demonstrated, with either controlled
rupture of the external iliac artery only (Fig 2), or with
controlled rupture of both the external and common iliac
artery with preservation of the hypogastric artery (Fig 3).
For both alternative access approaches, percutaneous
access is obtained through the contralateral femoral artery
for placement of a 5 French (F) sheath (8 F in case intravas-
cular ultrasound was used), and a calibrated ﬂush catheter.
The thoracic stent graft procedure is then performed as
previously described.13
In this study the TAG (W. L. Gore & Associates; n ¼
29), TX2 (Cook Medical Inc, Bloomington, Ind; n ¼ 5),
and AneuRx and Talent (Medtronic Inc, Minneapolis,
Minn; n ¼ 5) stent grafts were used for TEVAR. No major
differences in trackability were identiﬁed between the
different stent graft systems. Before closure of the wound,
Fig 1. Key steps of the endoconduit (EC) approach. A, Left iliac angiogram demonstrates a stenotic segment in the left
common iliac artery and a high grade stenosis of the origin of the left hypogastric artery. Because of the small caliber left
external iliac artery and delivery sheath occlusion, no ﬁlling with contrast was identiﬁed in this vessel. We believe that this
patient required an alternative access approach and in this case the EC approach was chosen. B, A balloon was advanced
from the left femoral artery access and placed in the left common iliac artery to perform angioplasty of the critical stenotic
segment. After angioplasty the entire left common iliac artery segment is theoretically large enough to be able to advance
the requireddelivery sheath (24 French).C,The internal ECwas partially deployed in the left external iliac artery.D,From
the contralateral/right side a balloonwas placed in the ipsilateral/left proximal common iliac artery. In cases with a widely
patent internal iliac artery, a compliant balloon is sometimes extended into the ipsilateral hypogastric artery. After this
proximal control is established, angioplasty and subsequent controlled rupture of the midportion of the left external iliac
artery is performed. E, A control angiogram was performed to detect if the patient had ongoing hemorrhage. The iliac
arteriogram revealed extravasation of contrast into the pelvis at the proximal landing zone of the iliac stent graft. F,
Treatment was proximally extended into the common iliac artery. After extension proximally with two stent grafts in the
left common iliac artery to the aortic bifurcation and eventually relining the entire iliac segment with another stent graft, a
ﬁnal control angiogram showed an excluded endoleak without extravasation of contrast into the pelvis. Note crosspelvic
collateralsﬁlled distal left hypogastric artery branches after coverage of the origin of the left hypogastric origin.Right to left
collaterals were well developed because of pre-existing high grade stenosis of the origin of the left hypogastric artery.
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sels were routinely performed. Completion imaging of
the iliofemoral section was selectively performed for altered
pulses or Doppler signals. ABIs were obtained routinely on
the ﬁrst or second postoperative day.Statistical analysis. Statistical analysis was performed
using IBM SPSS Statistics version 21.0 (SPSS Inc, Chicago,
Ill). Dichotomous variables were analyzed using the c2 test
or Fisher exact test; continuous variables were analyzed us-
ing Student t-test or Mann-Whitney U test for variables
Fig 2. The endoconduit (EC) approach of the external iliac artery only.A,Amarker pigtail catheter was used tomeasure
the length of the iliac artery and a right iliac angiogram was performed, which showed a widely patent origin of the right
hypogastric artery. In this patient the right common iliac arterywas of adequate diameter andonly right external iliac artery
disease appeared to preclude passage of the 24 French stent graft delivery sheath. Therefore, an EC approach bridging the
right external iliac arterywas chosen.B,The stent graftwas deployed in the right external iliac artery andwas narrowedby a
stenotic segment in themiddle portionof this vessel.C,By advancing a sheath fromthe contralateral/left side andplacing a
compliant balloon into the ipsilateral/right common and internal iliac arteries, proximal control of the iliofemoral system
was established. After proximal control, the right external iliac artery is intentionally ruptured in a controlled fashion. The
catheter from the contralateral/left side is placed into the right hypogastric artery, for two additional reasons. It marks the
origin of the hypogastric artery to aid precise placement of the EC. It alsomaintains access to the right hypogastric artery in
case coiling of the vessel origin is required. D, Retrograde injection of contrast showed no extravasation. Passage of the
stent graft delivery sheath (24 French) was smooth and uneventful.
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using Kaplan-Meier methods.
RESULTS
Patient characteristics. Most of the patients were fe-
male (82.1%), Caucasian (87.2%), and underwent TEVARfor thoracic aortic aneurysm (64.1%). Other thoracic aortic
pathologies treated with TEVAR included type B aortic
dissection (10.3%; the dissection in all of these cases did
not involve the iliac arteries), aortic rupture (15.4%),
thoracic aortic injury (2.6%), penetrating aortic ulcer
(2.6%), and intramural hematoma (5.1%). The median
Fig 3. The endoconduit (EC) approach for the common and external iliac arteries with preservation of the hypogastric
artery. A, The preoperative three-dimensional reconstruction of the aorta and iliofemoral system is shown. This patient
was selected for thoracic endovascular aortic repair (TEVAR) with an EC approach for the right common iliac artery,
and the right external iliac artery was considered of adequate size to pass the required stent graft delivery sheath.
Preoperatively, this patient was considered to be at high risk for paraplegia and therefore preservation of the hypogastric
artery was desirable. B, The EC was dilated after deployment in the right common iliac artery. C, The femoral artery
sheath could not be advanced into the aorta because of resistance in the proximal right external iliac artery, with the
arteriogram showing narrowing of the iliac bifurcation and the proximal right external iliac artery. D, Another stent
graft was deployed in the right external iliac artery with preservation of the origin of the right hypogastric artery. As the
stent graft was post dilated with the balloon, the narrowed middle portion of the right external iliac artery was
intentionally ruptured. The iliac artery segment at the level of the origin of the hypogastric artery was of normal caliber
allowing passage of a stent graft delivery sheath (24 French) without risking uncontrolled iliac artery rupture in that
section. E, A control angiogram shows no extravasation of contrast into the pelvis and preservation of the right hy-
pogastric artery between the proximal and distal ECs. F, Postoperative three-dimensional reconstruction of the ilio-
femoral tract demonstrated ECs in the right iliac artery with preservation of the right hypogastric artery.
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3.1-29.0 months).
Preoperative comorbidity, including diabetes, chronic
obstructive lung disease, renal failure, dialysis, cerebrovas-
cular accident, myocardial infarction, previous aortic sur-
gery, percutaneous coronary intervention, coronary artery
bypass grafting, and coronary artery disease were not signif-
icantly different between groups. Hypertension was more
frequently seen in the EC group (100% vs ROIC, 73.9%;
P ¼ .026). A univariate comparative analysis between the
two stent graft delivery approaches regarding patient char-
acteristics and preoperative comorbidities is shown in
Table II.Early results. In the ROIC and EC cohorts, there
were no signiﬁcant differences identiﬁed between interven-
tion details including the performance of previous left ca-
rotid to subclavian bypass, placement of a lumbar drain,
the segment of aorta treated using TEVAR (the aortic
arch, descending and/or abdominal aorta), and number
and type of thoracic stent graft used. The stent graft deliv-
ery sheath size was larger for the ROIC approach (24.0 F
vs EC 22.9 F; P ¼ .038).
Of all patients, 20.5% experienced iliofemoral compli-
cations (EC, n ¼ 2 [12.5%] vs ROIC, n ¼ 6 [26.1%];
P ¼ .301). Complications occurred in two patients in the
EC group. The ﬁrst patient was a 75-year-old female
Table II. Demographic characteristics and comorbidities
Variable EC (n ¼ 16) ROIC (n ¼ 23) P
Age, years 72.6 6 7.1 72.3 6 13.9 .936
Female sex 13 (81.3) 19 (82.6) 1.000
Diabetes 1 (6.3) 4 (17.4) .306
Coronary artery disease 7 (43.8) 11 (47.8) .802
Previous CVA 4 (25.0) 2 (8.7) .165
Previous CABG 3 (18.8) 6 (26.1) .593
Previous PCI 1 (6.3) 0 (0) .225
Hypertension 16 (100) 17 (73.9) .026
COPD 7 (43.8) 11 (47.8) .802
History of tobacco use 14 (87.5) 21 (91.3) .700
PVOD 7 (43.8) 8 (34.8) .740
Preoperative ipsilateral ABI 0.96 6 0.25 1.03 6 0.09 .361
Preoperative creatinine, mg/dL 1.6 6 1.5 1.0 6 0.3 .176
Dialysis-dependent renal failure 2 (12.5) 0 (0) .082
Previous aortic surgery 7 (43.8) 10 (43.5) .987
Previous AAA repair (all open repair) 4 (25.0) 3 (13.0) .339
Maximum aortic dimension, mm 65.5 6 16.1 60.2 6 9.9 .214
AAA, Abdominal aortic aneurysm; ABI, ankle-brachial index; CABG, coronary artery bypass grafting; COPD, chronic obstructive lung disease; CVA, ce-
rebrovascular accident; EC, endoconduit; PCI, percutaneous coronary intervention; PVOD, peripheral vascular occlusive disease; ROIC, retroperitoneal open
iliac conduit.
Continuous data are presented as mean 6 standard deviation and categoric data as number (%).
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was at high risk for open surgery, and was treated with
TEVAR for a thoracoabdominal aneurysm. Because of
poor iliofemoral anatomy on the contralateral side, she sus-
tained femoral artery bleeding on this side and required pri-
mary femoral artery repair with groin hematoma evacuation
and vacuum-assisted closure placement. She died as sequelae
of this contralateral access complication and spinal cord
ischemia, and was the only early mortality in our cohort.
The second patient underwent ipsilateral lower extremity
fasciotomy for lower extremity compartment syndrome on
the access side. This patient likely sustained prolonged
ischemia because of the prolonged indwelling sheath time
of 6.5 hours, and inadequate collateral circulation as evi-
denced by poor backbleeding from the distal femoral artery
identiﬁed during its primary repair. Hypogastric artery back-
bleeding was not identiﬁed in any patient in the EC cohort.
The six iliofemoral complications for the ROIC tech-
nique included: ipsilateral common femoral artery embo-
lectomy with angioplasty for an ischemic leg (n ¼ 1),
reoperation for fascial dehiscence (n ¼ 1), retroperitoneal
hematoma requiring exploration and evacuation (n ¼ 2),
intraoperative rupture of the anastomosis between the
conduit and the iliac artery on removal of the sheath
(n ¼ 1), and abdominal wound infection (n ¼ 1). Major
complications such as spinal cord ischemia, early cerebro-
vascular accident, renal failure requiring dialysis, and need
for tracheostomy were not signiﬁcantly different between
the ROIC and EC groups (Table III).
Late results. No limb loss occurred in our patient
cohort and one EC patient developed lower extremity clau-
dication during follow-up. Revascularization was per-
formed in two ROIC patients; one for an ischemic
contralateral leg requiring left common femoral artery
embolectomy, and one who underwent a contralateralcommon and superﬁcial femoral endarterectomy with patch
angioplasty using a bovine pericardial patch for dissection of
the superﬁcial femoral artery. A univariate comparative
analysis of the procedural details and outcomes between the
EC and ROIC techniques is shown in Table III.
No signiﬁcant differences were found regarding iliac
artery morphology between the ROIC and EC approach.
The comparative analysis for iliac artery-speciﬁc details is
shown in Table IV. Two-year Kaplan-Meier survival for
the entire cohort was 74.4%, and did not differ between
groups (ROIC, 78.3% vs EC, 68.8%; P ¼ .350; Fig 4).
Also, 2-year Kaplan-Meier freedom from limb loss, claudi-
cation, or revascularization did not differ between the
approaches (ROIC, 91.3% vs EC, 93.8%; P ¼ .961; Fig 5).
DISCUSSION
TEVAR has been widely implemented into clinical
practice as the preferred treatment modality for thoracic
aortic pathology.1-4 Despite its less invasive nature, there
still remain important limitations. Previous work has sug-
gested that the applicability of TEVAR is limited not
only by compromised proximal and distal landing zones,
but also by difﬁculties with vascular access (diseased or
tortuous iliac arteries, or a small-caliber infrarenal aorta).14
Alternative stent graft delivery techniques are required
frequently, because 9% to 21% of patients who undergo
TEVAR will require an iliac conduit for device deliv-
ery.3,15-17 This rate does not include patients not selected
for TEVAR because of prohibitive iliofemoral anatomy.
Peterson and Matsumura initially described the EC
approach as an alternative stent graft delivery technique
using TEVAR.11 In 2009, when a patient presented to
the University of Michigan with a ruptured penetrating
ulcer in the descending aorta, marginal hemodynamics,
and poor iliofemoral access, we used the EC approach to
Table III. Procedural details and outcome
Variable EC (n ¼ 16) ROIC (n ¼ 23) P
Procedural details
Access side left 8 (50.0) 13 (56.5) .752
Device delivery sheath size, French 22.9 6 1.7 24.0 6 1.0 .038
Operative time, median (interquartile range) 317 (261-399) 273 (227-347) .256
Preoperative hematocrit, % 33.5 6 5.6 36.4 6 5.3 .109
Blood loss, mL 1232 6 887 772 6 586 .083
Blood products 2.5 6 2.5 1.9 6 2.9 .562
No. of thoracic stent grafts 2.3 6 1.0 2.4 6 0.8 .537
Maximum diameter implanted thoracic stent graft, mm 39.8 6 5.5 39.1 6 4.5 .700
Outcome
Iliofemoral complication 2 (12.5) 6 (26.1) .301
Limb loss 0 (0) 0 (0) NS
Claudication 1 (6.3) 0 (0) .225
Revascularization 0 (0) 2 (8.7) .226
30-Day mortality 1 (6.3) 0 (0) .225
Postoperative ipsilateral ABI 0.97 6 0.22 1.06 6 0.10 .186
Difference between pre- and postoperative ABI 0.02 6 0.28 0.02 6 0.08 .908
Hospital stay, days 13.3 6 11.4 10.2 6 7.3 .309
Follow-up, months 10.4 6 11.5 23.1 6 22.4 .027
Permanent SCI 1 (6.3) 2 (8.7) .778
CVA 0 (0) 1 (4.3) .398
Postoperative creatinine at postoperative day 1, mg/dL 1.4 6 1.6 1.1 6 0.4 .342
Iliofemoral reoperation 1 (6.3) 3 (13.0) .492
ABI, Ankle-brachial index; CVA, cerebrovascular accident; EC, endoconduit; NS, not signiﬁcant; SCI, spinal cord ischemia; ROIC, retroperitoneal open iliac
conduit.
Unless otherwise speciﬁed, continuous data are presented as mean 6 standard deviation and categoric data as number (%).
Table IV. Iliac artery speciﬁc details
Variable EC (n ¼ 16) ROIC (n ¼ 23) P
Iliac calcium score 1.81 6 1.05 1.65 6 1.06 .655
Average iliac diameter, mm 6.89 6 1.54 7.39 6 1.21 .327
Minimum iliac diameter, mm 5.09 6 1.04 5.63 6 0.99 .128
Iliac tortuosity index 1.27 6 0.23 1.16 6 0.11 .235
IMS 4.89 6 2.37 3.89 6 1.17 .279
Sheath oversizing, mm 0.85 6 1.63 0.77 6 1.24 .881
EC, Endoconduit; IMS, iliac morphology score; ROIC, retroperitoneal open iliac conduit.
Data are presented as mean 6 standard deviation.
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this successful index procedure, we attempted to use this
technique selectively in lieu of iliac artery conduits for
device delivery. The current study is our attempt to evaluate
this early experience using the EC approach, and is unique
for two reasons. First, the cohort is much larger than previ-
ously reported; and second, to our knowledge, this is the ﬁrst
comparative analysis between ROIC and EC approaches as
alternative stent graft delivery techniques.
Preoperative evaluation of the iliofemoral arterial sys-
tem is essential in planning TEVAR. It has been demon-
strated that iliofemoral complications for the standard
femoral approach were associated with increased iliac artery
morphology score, ABI, and difference between average
iliac diameter and sheath size.5 The optimal method to
evaluate the iliac artery anatomy for TEVAR is ﬁne-cut
computed tomography angiography imaging of the iliofe-
moral arteries. Caution is required when traversing calciﬁed
tortuous iliac arteries in elderly patients, and device delivery
can result in catastrophic iliac artery rupture.Since the introduction of endovascular aortic repair,
the ROIC technique has traditionally been the most
commonly used alternative approach for stent graft deliv-
ery. Previous experience using this technique for endovas-
cular abdominal aneurysm repair suggested that it was
associated with an increased rate of complications
compared with the transfemoral delivery, including greater
blood loss, longer procedure time, longer hospital stay, and
a higher rate of perioperative complications compared with
standard femoral exposure.7 Similar results in a patient
group focused on TEVAR have been reported.18 Further-
more, prosthetic material is typically left behind using the
ROIC approach, which raises the concern for potential
graft infection. In contrast, elective conduits avoid poten-
tially life-threatening iliac complications associated with
advancing large bore sheaths through diseased or tortuous
iliofemoral arteries. Despite the increased morbidity, no
signiﬁcant difference in early mortality has been demon-
strated for this approach.7,18 Our study similarly demon-
strated higher rates of iliofemoral complications in the
Fig 5. Freedom from late limb loss, claudication, or revasculari-
zation. Two-year Kaplan-Meier analysis between the retroperito-
neal open iliac conduit (ROIC) and endoconduit (EC) approaches
is shown with the numbers at risk at 0, 12, and 24 months. Cumu-
lative surviving time is 75.0 6 21.7% at 2 years. The standard error
exceeds 10% after 14 months for the EC approach and does not
exceed 10% for the ROIC approach during the 2-year follow-up.
Fig 4. Two-year Kaplan-Meier survival curve for the endoconduit
(EC) vs the retroperitoneal open iliac conduit (ROIC) approach,
with the numbers at risk demonstrated for the two different ap-
proaches at 0, 12, and 24 months. Cumulative surviving time is
66.1 6 12.5% at 2 years. The standard error exceeds 10% after
4 months for the EC approach and after 13 months for the ROIC
approach.
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mortality rates.
Internal ECs allow for adequate angioplasty without
risking iliac artery rupture in an uncontrolled fashion, in
contrast to other techniques, such as adjunctive balloon an-
gioplasty, or in situ introducer sheath dilatation.9,19 When
appropriate distal and proximal seal is accomplished using
the EC, aggressive angioplasty can be performed with less
risk for catastrophic hemorrhage.11 Using the EC approach,
patients can be treated via a standard femoral artery access,
even in the presence of signiﬁcant iliac occlusive disease or
other adverse iliac anatomy. Moreover, the morbidity asso-
ciated with the retroperitoneal approach is avoided. Our
study demonstrated comparable rates of iliofemoral compli-
cations for the EC (12.5%) compared with the standard
femoral access technique.5 Our study shows acceptable early
results, and a study with a larger sample size would be an
important next step to conﬁrm our ﬁndings.
One of the major concerns with ECs is the possible
coverage of the origin of the hypogastric artery, with asso-
ciated complications such as spinal cord ischemia, gluteal
necrosis, and buttock claudication. When covering the
origin of the hypogastric artery, collateral circulation
should be optimally assisted and if possible maintained,
preserving the inferior epigastric and superﬁcial circumﬂex
iliac arteries to optimize pelvic perfusion. When occlusion
of the hypogastric artery origin is required with an EC,
we consider coiling the origin of this artery if it is widely
patent, to avoid hemorrhage via cross-pelvic collateral
circulation. If high-grade stenosis of the origin of the hypo-
gastric artery is present, coiling is not routinely performed.
Based on these considerations, when both iliac arteries havecritical stenoses, we select the more diseased side as the
access site for EC placement.
It is important to note that a selection bias might be
present in our study, because four groups of patients are
not selected for the EC technique in our practice. These
include: (1) patients with severe narrowing or calciﬁcation
of the aortic bifurcation; (2) patients with a single hypogas-
tric artery requiring coverage with the internal EC (ie,
stenotic segment at the level of the origin of the hypogas-
tric artery or previous abdominal aortic aneurysm repair
with extensive coverage of the aortoiliac segment); (3)
femoral vessel inadequacy, not amenable to repair because
of severe calciﬁcation or stenosis; and (4) extensive dissec-
tion of the iliofemoral vessels. The ROIC approach remains
an important alternative for stent graft delivery in patients
with unfavorable iliac artery anatomy.
Limitations. The relatively small number of patients in
our study makes it difﬁcult to assign deﬁnitive conclusions
regarding preoperative morbidity, intraoperative details,
and outcome. Also, the length of follow-up for the EC
technique is relatively short because of the recent intro-
duction of the EC approach, and therefore longer-term data
are needed. However, the most essential outcomes to assess,
including iliofemoral complications, claudication, revascu-
larization, limb loss, and early mortality, are the most rele-
vant to widely implement this new access technique into
clinical practice. Nevertheless, the purpose of this small se-
ries was to evaluate the feasibility of this approach and
compare it with the gold standard alternative access.
In future studies larger cohorts should be studied to validate
the EC technique as an alternative access technique with
TEVAR.
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This early comparative evaluation of alternative access
routes for TEVAR suggests that the EC approach
described herein is safe, effective, and associated with low
rates of early mortality and late iliofemoral complications.
Internal ECs avoid complications associated with a retro-
peritoneal approach and allows transfemoral TEVAR.
With the expansion of endovascular therapies including
aneurysm repair and transcatheter aortic valve replacement,
the EC may be considered a suitable delivery route for
selected patients.
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